(Q46931621)

26 December 2017

title

Overproduction of large VLDL particles is driven by increased liver fat content in man. (English)

1 reference

26 December 2017

10

H Yki-Järvinen

1 reference

26 December 2017

11

J Borén

1 reference

26 December 2017

author name string

M Adiels

1

1 reference

26 December 2017

M-R Taskinen

2

1 reference

26 December 2017

C Packard

3

1 reference

26 December 2017

M J Caslake

4

1 reference

26 December 2017

A Soro-Paavonen

5

1 reference

26 December 2017

J Westerbacka

6

1 reference

26 December 2017

S Vehkavaara

7

1 reference

26 December 2017

A Häkkinen

8

1 reference

26 December 2017

S-O Olofsson

9

1 reference

26 December 2017

publication date

4 February 2006

1 reference

26 December 2017

published in

Diabetologia

1 reference

26 December 2017

volume

49

1 reference

26 December 2017

issue

4

1 reference

26 December 2017

page(s)

755-765

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1007/s00125-005-0125-z

exact match

0 references

cites work

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

1 reference

12 December 2020

Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells: roles of MAPKerk and MAPKp38.

1 reference

12 December 2020

Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity

1 reference

12 December 2020

Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.

1 reference

12 December 2020

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

1 reference

12 December 2020

Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets

1 reference

12 December 2020

Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease

1 reference

12 December 2020

Hypoadiponectinemia is closely linked to endothelial dysfunction in man.

1 reference

12 December 2020

Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men.

1 reference

12 December 2020

Use and abuse of HOMA modeling

1 reference

12 December 2020

Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.

1 reference

12 December 2020

High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes

1 reference

12 December 2020

Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics?

1 reference

12 December 2020

Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk

1 reference

12 December 2020

Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia

1 reference

12 December 2020

Insulin sensitivity of suppression of endogenous glucose production is the single most important determinant of glucose tolerance

1 reference

12 December 2020

Glucose phosphorylation is essential for the turnover of neutral lipid and the second stage assembly of triacylglycerol-rich ApoB-containing lipoproteins in primary hepatocyte cultures

1 reference

12 December 2020

The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat.

1 reference

12 December 2020

LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins.

1 reference

12 December 2020

Insulin inhibits the maturation phase of VLDL assembly via a phosphoinositide 3-kinase-mediated event

1 reference

12 December 2020

Phosphoinositide 3-kinase activity is necessary for insulin-dependent inhibition of apolipoprotein B secretion by rat hepatocytes and localizes to the endoplasmic reticulum

1 reference

12 December 2020

Splanchnic lipolysis in human obesity

1 reference

12 December 2020

Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

12 December 2020

Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes

1 reference

12 December 2020

Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects

1 reference

12 December 2020

Synthesis and function of hepatic very-low-density lipoprotein

1 reference

12 December 2020

Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes

1 reference

12 December 2020

Glucose and insulin function through two distinct transcription factors to stimulate expression of lipogenic enzyme genes in liver.

1 reference

12 December 2020

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

1 reference

12 December 2020

The fatty liver and insulin resistance

1 reference

12 December 2020

Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus

1 reference

12 December 2020

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

12 December 2020

Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis

1 reference

12 December 2020

Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance

1 reference

12 December 2020

Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients

1 reference

12 December 2020

Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism

1 reference

12 December 2020

Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism

1 reference

12 December 2020

Adiponectin and Metabolic Syndrome

1 reference

12 December 2020

A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions

1 reference

12 December 2020

Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.

1 reference

12 December 2020

Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster

1 reference

12 December 2020

Quantification of liver fat using magnetic resonance spectroscopy

1 reference

12 December 2020

Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles.

1 reference

12 December 2020

Both Insulin Resistance and Diabetes inPsammomys obesusUpregulate the Hepatic Machinery Involved in Intracellular VLDL Assembly

1 reference

12 December 2020

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients

1 reference

12 December 2020

Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes

1 reference

12 December 2020

Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

1 reference

12 December 2020

Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance

1 reference

12 December 2020

Molecular mediators of hepatic steatosis and liver injury

1 reference

12 December 2020

Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM

1 reference

12 December 2020

Diabetic dyslipidaemia: from basic research to clinical practice.

1 reference

12 December 2020

10.1007/S00125-005-0125-Z

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

16463046

1 reference

26 December 2017